Biotech · Private company
Orum Therapeutics USA, Inc.
Track this companyFree. Adds Orum Therapeutics USA, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ORM-1153Phase 1 · CD123+ Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- ORM-5029Phase 1 · HER2-positive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 ExpressionPHASE1 · RECRUITING · started Sep 23, 2026ClinicalTrials.gov NCT07809906 · fetched Nov 12, 2026
- Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid TumorsPHASE1 · TERMINATED · started Oct 3, 2022ClinicalTrials.gov NCT05511844 · fetched Nov 12, 2026